Development of lentiviral vectors for antiangiogenic gene delivery

Cancer Gene Therapy

Volumn 8, Issue 11, 2001, Pages 879-889

  Shichinohe, Toshiaki ^a   Bochner, Bernard H ^a   Mizutani, Kazuo ^a   Nishida, Miyako ^a   Hegerich Gilliam, Susan ^a   Naldini, Luigi ^b   Kasahara, Noriyuki ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Angiostatin; Endostatin; Lentivirus; Vector

Indexed keywords

ANGIOSTATIN; ENDOSTATIN; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; COXSACKIE VIRUS; CYTOTOXICITY; ENDOTHELIUM CELL; GENE TARGETING; HUMAN; HUMAN CELL; LENTIVIRINAE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; BLOTTING, WESTERN; CATTLE; CELL SURVIVAL; COCULTURE TECHNIQUES; COLLAGEN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOSTATINS; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

ADENOVIRIDAE; ANIMALIA; BOVINAE; COXSACKIEVIRUS; LENTIVIRUS;

EID: 0035190393     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700388     Document Type: Article

References (45)

1. What is the evidence that tumors are angiogenesis dependent?
2. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
3. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
4. The functions of thrombospondin-1 and -2
5. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
6. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
7. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
8. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
9. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
10. Therapeutic potentials of angiostatin in the treatment of cancer
11. Role of carbohydrate on angiostatin in the treatment of cancer
12. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA
13. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
14. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
15. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
16. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
17. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin
18. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
19. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
20. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles
21. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
22. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
23. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2
24. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector
25. A simplified system for generating recombinant adenoviruses
26. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
27. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site?
28. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH
29. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice
30. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
31. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
32. Definition of two angiogenic pathways by distinct alpha v integrins
33. Vascular integrin alpha(v)beta3: A new prognostic indicator in breast cancer
34. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
35. Interaction of vesicular stomatitis virus-G pseudotyped retrovirus with CD34+ and CD34+ CD38- hematopoietic progenitor cells
36. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes
37. Transbilayer distributions of red cell membrane phospholipids in unilamellar vesicles
38. Exposure of phosphatidylethanolamine on the surface of apoptotic cells
39. Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling
40. Membrane lipids of hepatocytes, Kupffer cells and endothelial cells
41. Phospholipid composition of cultured human endothelial cells
42. Lipid composition of cultured endothelial cells in relation to their growth
43. Use of octadecylrhodamine fluorescence dequenching to study vesicular stomatitis virus fusion with human aged red blood cells
44. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
45. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses